PULMONX CORPORATION (LUNG) Net income 2018–2025
PULMONX CORPORATION (LUNG) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$54.0MFY2025 · since FY2018: -$18.5M → -$54.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.0M | +4.2% |
| FY2024 | -$56.4M | +7.3% |
| FY2023 | -$60.8M | -3.3% |
| FY2022 | -$58.9M | -21.1% |
| FY2021 | -$48.7M | -51.0% |
| FY2020 | -$32.2M | -55.7% |
| FY2019 | -$20.7M | -12.0% |
| FY2018 | -$18.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LUNG financial trends
LUNG RevenueLUNG Net marginLUNG Gross profitLUNG Gross marginLUNG Operating incomeLUNG Operating marginLUNG Operating cash flowLUNG Free cash flowLUNG Capital expendituresLUNG Return on equityLUNG Stock buybacksLUNG Dividends paidLUNG Total assetsLUNG Total liabilitiesLUNG Shareholders’ equityLUNG overview →